GetTopicDetailResponse(id=ea6c469e094, topicName=小分子靶向藥物, introduction=小分子靶向藥物, content=null, image=null, comments=5, allHits=1217, url=https://h5.medsci.cn/topic?id=46970, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=33842, tagList=[TagDto(tagId=33842, tagName=小分子靶向藥物)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2046221, encodeId=9e2c2046221c7, content=<a href='/topic/show?id=ea6c469e094' target=_blank style='color:#2F92EE;'>#小分子靶向藥物#</a>, objectTitle=Liver Cancer：侖伐替尼（Lenvatinib）治療晚期肝細胞癌（HCC）失敗后的小分子靶向藥物治療的選擇, objectType=article, longId=211561, objectId=4f32211561f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f32211561f9, replyNumber=0, likeNumber=99, createdTime=2022-01-23, rootId=0, userName=爆笑小醫(yī), userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f32211561f9, moduleTitle=Liver Cancer：侖伐替尼（Lenvatinib）治療晚期肝細胞癌（HCC）失敗后的小分子靶向藥物治療的選擇, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4f32211561f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2046220, encodeId=8eb02046220bb, content=<a href='/topic/show?id=ea6c469e094' target=_blank style='color:#2F92EE;'>#小分子靶向藥物#</a>, objectTitle=新型CDK9小分子靶向藥物FIT-039，有望治療宮頸癌, objectType=article, longId=168049, objectId=57f4168049c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57f4168049c2, replyNumber=0, likeNumber=100, createdTime=2020-01-16, rootId=0, userName=爆笑小醫(yī), userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57f4168049c2, moduleTitle=新型CDK9小分子靶向藥物FIT-039，有望治療宮頸癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=57f4168049c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2046217, encodeId=faa3204621e02, content=<a href='/topic/show?id=ea6c469e094' target=_blank style='color:#2F92EE;'>#小分子靶向藥物#</a>, objectTitle=快速上手指南：NSCLC 小分子靶向藥物耐藥處理共識, objectType=article, longId=66782, objectId=413c66e824b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=413c66e824b, replyNumber=0, likeNumber=122, createdTime=2016-05-21, rootId=0, userName=hyf028, userId=7d40148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=413c66e824b, moduleTitle=快速上手指南：NSCLC 小分子靶向藥物耐藥處理共識, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=413c66e824b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2046219, encodeId=e831204621917, content=<a href='/topic/show?id=ea6c469e094' target=_blank style='color:#2F92EE;'>#小分子靶向藥物#</a>, objectTitle=2015非小細胞肺癌小分子靶向藥物耐藥處理共識發(fā)布, objectType=article, longId=77607, objectId=08cee760765, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08cee760765, replyNumber=0, likeNumber=93, createdTime=2017-05-15, rootId=0, userName=hyf028, userId=7d40148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08cee760765, moduleTitle=2015非小細胞肺癌小分子靶向藥物耐藥處理共識發(fā)布, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=08cee760765)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2046218, encodeId=f2682046218ef, content=<a href='/topic/show?id=ea6c469e094' target=_blank style='color:#2F92EE;'>#小分子靶向藥物#</a>, objectTitle=ASCO 2016：中國自主創(chuàng)新小分子靶向藥物?？颂婺帷狢ONVINCE研究結果揭曉, objectType=article, longId=70154, objectId=f312e015453, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f312e015453, replyNumber=0, likeNumber=103, createdTime=2017-01-05, rootId=0, userName=hyf028, userId=7d40148, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f312e015453, moduleTitle=ASCO 2016：中國自主創(chuàng)新小分子靶向藥物?？颂婺帷狢ONVINCE研究結果揭曉, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f312e015453)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
